Peptide profile · Hormone Support
Nafarelin
A potent GnRH agonist that initially stimulates then suppresses reproductive hormones, used for treating endometriosis and central precocious puberty with convenient nasal spray delivery.
Written & reviewed by Michael Carroll · Research, Peptide Initiative
Typical dose
400 mcg/day (one 200 mcg spray each nostril, AM and PM)
Half-life
Approximately 2-6 hours (varies by route of administration)
Bioavailability
~2-3% (intranasal)
Molecular weight
1322.5 g/mol
Evidence level
Strong human trials
01 · Compound profile
Scientific & efficacy data
Molecular formula
C66H83N17O13
Primary benefits
Reduces severe endometriosis pain and cramping significantly within weeks
Manages precocious puberty progression and decreases abnormal vaginal bleeding
Creates predictable hormone suppression for therapeutic effect with reversible outcomes
Searle (later Pharmacia/Pfizer)
Amino acid sequence
pGlu-His-Trp-Ser-Tyr-D-2-Nal-Leu-Arg-Pro-Gly-NH202 · Dosing
How much do I take?
400 mcg/day (one 200 mcg spray each nostril, AM and PM) · twice daily
Intranasal: Sprayed into the nose, where it absorbs through the nasal lining.
Bioavailability Moderate — absorbs through the nasal lining and can partly bypass the gut.
Best time to take
Use Nafarelin at the same time each day for optimal results. Consistency in timing helps maintain stable levels and maximize therapeutic benefits. Follow your healthcare provider's specific instructions.
With food?
Nafarelin can generally be used with or without food. If you experience any discomfort, try taking it with a light meal. Follow specific guidance from your healthcare provider.
If stacking
Nafarelin should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
＋ Increase if
- +You've tolerated the current dose for the recommended period without significant side effects
- +Therapeutic goals haven't been met at the current dose level
- +Your healthcare provider recommends dose escalation based on your response
- +Lab work or clinical assessments support a higher dose
－ Decrease if
- −Side effects are bothersome or impacting daily life despite management strategies
- −You experience any signs of an adverse reaction
- −Lab results indicate the need for dose reduction
- −Your healthcare provider recommends a lower dose based on your response
✓ Signs of right dose
- ✓Therapeutic goals being met with minimal side effects
- ✓Stable and consistent response to treatment
- ✓Lab values or clinical markers trending in the right direction
- ✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
03 · Suitability
Is this right for me?
Best for managing moderate to severe endometriosis pain that doesn't respond to other treatments & treating children with precocious puberty (early puberty)
Best for
Managing moderate to severe endometriosis pain that doesn't respond to other treatments
Nafarelin is particularly well-suited for individuals focused on managing moderate to severe endometriosis pain that doesn't respond to other treatments. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Treating children with precocious puberty (early puberty)
Nafarelin is particularly well-suited for individuals focused on treating children with precocious puberty (early puberty). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Preparing women for endometriosis surgery by reducing inflammation
Nafarelin is particularly well-suited for individuals focused on preparing women for endometriosis surgery by reducing inflammation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Improving fertility outcomes in assisted reproductive procedures
Nafarelin is particularly well-suited for individuals focused on improving fertility outcomes in assisted reproductive procedures. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Nafarelin with similar peptides to find the best fit for your goals.
04 · Administration
How do I use it?
As directed by healthcare provider
Reconstitution — what you need
Example
Add the recommended volume of bacteriostatic water to the Nafarelin vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.
Your dose of Nafarelin is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Technique
- 01Wash your hands thoroughly with soap and water before handling supplies
- 02Clean the injection site with an alcohol swab and let it air dry completely
- 03Pinch a fold of skin at the chosen injection site
- 04Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
- 05Inject the medication slowly and steadily over 5-10 seconds
- 06Release the skin fold and remove the needle, applying gentle pressure with a clean swab
- 07Rotate injection sites to prevent tissue irritation or lipodystrophy
- 08Dispose of the needle safely in a sharps container—never recap or reuse needles
Storage · before reconstitution
Store Nafarelin in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
Storage · after reconstitution
Once reconstituted, Nafarelin should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation
Sample daily schedule
05 · Safety
Is it safe?
30 common side effects · 2 serious
Nafarelin is FDA-approved with a well-established safety profile across decades of clinical use for endometriosis and precocious puberty. The most significant safety consideration is hypogonadism and bone density loss during prolonged therapy, requiring add-back therapy (norethindrone 0.4 mg daily) after 6 months to prevent osteoporosis. Common side effects—hot flashes, vaginal dryness, mood changes—are reversible upon discontinuation and typically diminish with continued use.
FDA approval based on multiple randomized controlled trials in endometriosis (n=1000+) showing superior efficacy versus danazol with improved tolerability. Long-term safety data from 20+ years of clinical use demonstrates Class III osteoporosis risk after 12 months without add-back therapy, measured via DEXA scans. Cardiovascular effects minimal; lipid profile changes are modest and reversible.
Common side effects · experienced by some users
Stop and seek help if
- ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
- ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- ×Your healthcare provider recommends discontinuation based on your clinical response
- ×Development of any new medical condition that may be contraindicated with Nafarelin
- ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- ×Abnormal lab results or clinical markers that suggest adverse effects
Nafarelin should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- ✓BPC-157 — No known direct interaction with Nafarelin. BPC-157 is sometimes used for its gut-protective properties, which could theoretically help manage GI side effects.
With medications
- ✓Blood thinners (warfarin, heparin) — Monitor closely if combining with Nafarelin as interactions may affect bleeding risk or drug metabolism.
With supplements
- ✓Multivitamins — Generally safe to take alongside Nafarelin. Space doses apart if taking oral formulations to ensure optimal absorption.
- ✓Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
06 · Effectiveness
How do I know it's working?
Strong human trials · first signs days 1-3
Evidence level
Strong human trials
(Phase 3 or FDA approved)
How it works
Nafarelin is a GnRH agonist that tricks your pituitary gland into shutting down estrogen and testosterone production. For endometriosis, lower estrogen means less tissue growth and pain. For early puberty in kids, lower hormones slow sexual development. The nasal spray makes it convenient—just a couple of sprays twice a day instead of daily injections.
Nafarelin is a synthetic GnRH agonist decapeptide with D-2-naphthylalanine substitution at position 6 and N-terminal pyroglutamation that provides enhanced receptor binding and resistance to enzymatic degradation. Upon administration (intranasal), nafarelin binds pituitary GnRH receptors with high affinity, initially causing acute FSH and LH release (flare phase, 7-14 days). Continuous nafarelin exposure leads to receptor desensitization and downregulation, suppressing gonadotropin secretion below baseline. In women, this reduces estrogen production; in children with precocious puberty, it suppresses the pubertal hormone axis. The intranasal route provides convenient non-injectable delivery with approximately 2-3% bioavailability, enabling twice-daily dosing. Estrogen suppression of 90%+ is achieved within 3-4 weeks, maintaining suppression throughout treatment duration.
What to expect
Days 1-3
What you might notice
- •Initial injection flare - hormone levels spike briefly before dropping
- •Some patients experience temporary worsening of symptoms
- •Pituitary begins responding to the medication
What's normal
- •Initial response to Nafarelin is beginning at the cellular level
- •Different individuals experience Nafarelin's onset at different rates
- •Transient systemic effects from initial Nafarelin exposure are common
What's next
- →Maintain consistent Nafarelin administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
Weeks 1-2
What you might notice
- •Hot flashes and night sweats typically begin
- •Hormone suppression starts becoming noticeable
- •Women may begin experiencing menopause-like symptoms
What's normal
- •Nafarelin has achieved stable, long-term homeostatic integration
- •Sustained efficacy of Nafarelin remains consistent
- •Chronic Nafarelin effects remain stable and predictable
What's next
- →Maintain your established Nafarelin protocol for sustained benefits
- →Continue periodic monitoring to confirm Nafarelin efficacy
- →Review comprehensive Nafarelin response with your provider
Weeks 3-4
What you might notice
- •Significant hormone level suppression achieved
- •Endometrial lesions begin shrinking
- •Pain levels often start improving noticeably
What's normal
- •Nafarelin is now achieving steady-state pharmacokinetics
- •Measurable changes aligned with Nafarelin's mechanism may appear
- •Initial adjustment effects typically resolve by this point
What's next
- →Maintain Nafarelin dosing exactly as established
- →Track progress toward intended outcomes in detail
- →Review lab work or biomarker changes with your healthcare team
Weeks 4-8
What you might notice
- •Maximum symptom improvement usually reached
- •Pain relief becomes significant
- •Menstrual-like symptoms typically stop
What's normal
- •Nafarelin is now achieving steady-state pharmacokinetics
- •Measurable changes aligned with Nafarelin's mechanism may appear
- •Initial adjustment effects typically resolve by this point
What's next
- →Maintain Nafarelin dosing exactly as established
- →Track progress toward intended outcomes in detail
- →Review lab work or biomarker changes with your healthcare team
Months 3-6
What you might notice
- •Peak therapeutic benefit maintained
- •Endometrial lesions significantly smaller
- •Patients report major quality-of-life improvements
What's normal
- •Nafarelin has achieved stable, long-term homeostatic integration
- •Sustained efficacy of Nafarelin remains consistent
- •Chronic Nafarelin effects remain stable and predictable
What's next
- →Maintain your established Nafarelin protocol for sustained benefits
- →Continue periodic monitoring to confirm Nafarelin efficacy
- →Review comprehensive Nafarelin response with your provider
After Stopping Treatment
What you might notice
- •Pituitary function gradually returns to normal over several weeks
- •Menstrual cycles and hormone levels restart
- •Fertility typically returns within 3 months
What's normal
- •Full therapeutic effects of Nafarelin are well-characterized at this point
- •Maintenance of Nafarelin's therapeutic effects is typical
- •Tolerance patterns with Nafarelin are generally stable over months
What's next
- →Comprehensive assessment of Nafarelin efficacy should be conducted
- →Discuss long-term continuation, cycling, or protocol modifications
- →Continue regular monitoring of relevant biomarkers or symptoms
Signs it's working · Treatment Response
- ✓Improvement in the primary symptoms or condition being treated
- ✓Positive changes in relevant lab values or clinical markers
- ✓Consistent, stable response to Nafarelin over time
- ✓Reduction in symptom frequency or severity
Signs it's working · General Well-being
- ✓Improved energy levels and daily functioning
- ✓Better quality of life related to the treated condition
- ✓Manageable or absent side effects indicating good tolerance
- ✓Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- •Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- •Insufficient time at target dose—most compounds need several weeks to show full benefits
- •Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- •Individual variation in response—genetics, metabolism, and other factors affect outcomes
- •Underlying conditions or medications interfering with absorption or effectiveness
- •Improper storage leading to degraded product—always verify proper storage conditions
Key research
07 · Questions
Frequently asked
How quickly does Nafarelin work for endometriosis pain?+
Pain relief is usually noticeable within 3-4 weeks, with maximum benefit by 8 weeks. Some people feel improvement within the first 2 weeks, while others take longer. The hot flashes and night sweats start almost immediately though, sometimes within days.
Will I get my period back after stopping Nafarelin?+
Yes! Your menstrual cycle almost always returns within 1-3 months after finishing treatment. Your fertility typically returns at the same time. This is one of the biggest advantages over surgical treatment - your body goes back to normal.
Can I get pregnant while using Nafarelin?+
No - Nafarelin suppresses your reproductive hormones, which prevents pregnancy. You must use non-hormonal birth control (like condoms) during treatment. Once you stop the medication, you can try to get pregnant whenever you're ready, as fertility usually returns quickly.
How bad are the hot flashes really?+
They vary by person. Some people have mild warmth a few times daily, while others experience intense sweating and flushing many times per day. Most people find them manageable but uncomfortable. The good news is they usually improve after the first month and stop completely once you finish treatment.
Can I use Nafarelin for more than 6 months?+
Most doctors limit continuous use to 6 months because of bone loss concerns. However, some doctors may recommend 12 months in severe cases, usually with add-back hormone therapy to protect your bones. Extended use is typically reserved for situations where the benefit really outweighs the risks.
What happens if I miss a dose?+
Try to take it as soon as you remember, but skip it if it's almost time for your next dose. Don't double up on doses. Missing one or two doses occasionally won't ruin your treatment, but consistency is important for best results.
Is Nafarelin safe for teenagers with precocious puberty?+
Yes, it's one of the standard treatments for precocious puberty in children and teenagers. The dosing is adjusted for body weight, and doctors monitor growth and development closely. It can help prevent adult height loss and other complications from early puberty.
08 · Further reading
History & related research
History · since 1990
The breakthrough spray that made hormone therapy easier to take
Nafarelin is a man-made hormone delivered as a nasal spray that helps treat endometriosis and early puberty. Instead of injections, patients simply spray it in their nose twice a day.
Read the full history of Nafarelin